Clinical Study Site

Osaka 545-8586

1 studies enrolling now · 2 studies all time

What they study most

Fabry Disease, Metastatic Colorectal Cancer (CRC)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed